Skip to main content
. Author manuscript; available in PMC: 2020 Jan 23.
Published in final edited form as: Chem Rev. 2018 Oct 16;119(2):957–1057. doi: 10.1021/acs.chemrev.8b00363

Table 1:

ECF MRI contrast agents that have been used in the clinic.

ECF agent (Trade name) ECF agent (Chemical code) ECF agent (Generic name) Approval date
Dotarem, Clariscan Gd-DOTA gadoterate meglumine 1989 (Europe)
2013 (United States)
ProHance Gd-HPDO3A gadoteridol 1992
Gadovist (Europe)
Gadavist (United States)
Gd-DO3A-butrol gadobutrol 1998 (Europe)
2011 (United States)
Magnevista Gd-DTPA gadopentate dimeglumine 1988
Omniscana Gd-DTPA-BMA gadodiamide 1993
Optimarka Gd-DTPA-BMEA gadoversetamide 1999
Multihanceb, c Gd-BOPTA gadobenate dimeglumine 2004
a

agents suspended by the European Medicines Agency in 2017.

b

agent available for limited, liver-specific indications in the EU.

c

multipurpose agent that is also suitable for liver imaging.14

HHS Vulnerability Disclosure